Рет қаралды 132
Song Li earned his BS and MS from Peking University, and his PhD and postdoctoral training in bioengineering at the University of California San Diego. He was a professor of bioengineering at the University of California, Berkeley, from 2001 to 2015. In 2016, he joined the bioengineering faculty at the University of California, Los Angeles (UCLA). He is currently a Chancellor’s Professor and chair of the UCLA bioengineering department with a joint appointment in the Department of Medicine.
Li’s research is focused on mechanotransduction, cell engineering, and regenerative medicine. His lab takes an interdisciplinary approach to investigate mechanotransduction and biophysical regulation from single cell to system level and to develop therapeutics by engineering stem cells, immune cells, and micro/nanomaterials. Li has been elected an American Institute of Medical and Biological Engineering fellow, a Biomedical Engineering Society fellow, and an International Academy of Medical and Biological Engineering fellow.
This talk was given at the 2023 Symposium on Physical Genomics at Northwestern University, sponsored by the Center for Physical Genomics and Engineering and the Robert H. Lurie Comprehensive Cancer Center.